top of page
EnLiSense in the News
Advancing Care with Innovative Sweat Sensor Technology with Leading Clinicians
EnLiSense CCM, a pioneer in non-invasive, real-time inflammatory biomarker monitoring, announces the initiation of multiple groundbreaking clinical studies in collaboration with top-tier medical institutions to further the management of Chronic Diseases
Clinical Data from UChicago Supports Novel Continuous Calprotectin Monitoring Wearable for IBD Management
EnLiSense's IBD Aware device offers a pioneering solution for managing inflammatory bowel disease by continuously monitoring calprotectin levels non-invasively through innovative passive-perspiration sensor technology.
bottom of page